Conferences
Reports
Media
Professional Services
Educational Services
Shop
Checkout
CHI home
about
contact us
request information
Home
Upcoming Conferences
Short Courses
Global Web Symposia
Register
Purchase CD
Sponsor/Exhibit
Past Conferences
Co-Promoted Events
July 4, 2009
|
CHI Conferences
>
White Papers
Complimentary White Papers
A handheld device for potential point-of-care screening
Improved diagnostic accuracy of malignant neck lumps
The Importance of Cardiac Safety Assessments
Sources of variation in baseline gene expression
Comparative Oncology Trials Consortium
Managing Alliances in a Global Recession
New Frontiers: The Changing World of Biospecimen Collection and Management
A Systematic Approach To Biomarker Discovery
Importance of Preclinical Imaging in Drug Discovery
Network Analysis of Breast Cancer Gene Clusters
Systematic assessment of copy number variant detection
Improved Strategies for the Design of Clinical Trials
Stable in a Genome of Instability
Build vs. Buy: Considerations for EDC Investment
CRF: Patient Compliance Triples with e-Diaries
The eCTD - a Six-Month Checkup
Are we Approaching the post-blockbuster era?
New Directions for Personalized Medicine
Future of Cancer Diagnostics
Impact of DNA Microarrays on Molecular Diagnostics
Strategic Review of Cell Therapy Markets
Strategic Review of Cell Therapy Markets
Cancer Insight Compedium
21st Century Pharma
Leadership and Learning Best Practices
Partnering Best Practices For R&D Project Teams
Next-Generation Sequencing
Strategic Considerations for the U.S. Pharmaceutical Industry
A Collection of Interviews by Thomson CenterWatch
Breathing New Life into Structure-Based Design
An Update on Radio-Immunotherapy
Biological Functions of MicroRNAs
Biomarkers for Development of Cancer Vaccines
Bio-IT World Briefing On: Boosting Productivity In Healthcare
Common Factors Impacting the Utility and Commercialization of Any Cell Therapy
Current Challenges of Real-Time PCR Quantitation.
Creating an Alliance Management Capability
Diagnosis, Prognosis, and Therapy Selection
Drug Development: Last Frontier of Automation
Drug-Induced Torsade de Pointes and Implications for Drug Development
Doubling IT Innovation Spending: Laying the Foundation for IT-Enabled Business Process, Supply Chain, and Service Innovation in the Pharmaceutical Industry
Enterprise Strategy Execution
Exploiting the Untapped Promise of Drug Repositioning
Epigenetic Gene Regulation: Early Environmental Exposures (Future Medicine)
Genome-Based Biomarkers for Adverse Drug Effects, Patient enrichment and Prediction of Drug Response, and Their Incorporation Into Clinical Trial Design
How to Choose the Right Molecular Diagnostics Technology using a Decision Analysis Matrix
How To Make Dendritic Cells Work in Cancer
Implementing an Alliance-Dependent Strategy
Modulation Angiogenesis Pathway Using siRNA Inhibitors
Multi-color fluorescent proteins for in vivo imaging
Notes of a Protein Crystallographer: Quo Vadis Structural Biology?
Nucleic Acid Quantification and Disease Outcome Prediction in Colorectal Cancer
Magnetic Micro- and Nano-Particle-Based Targeting for Drug and Gene Delivery
Negotiating as a Cross-functional Project Manager: Lessons from Alliance Management
'Omics'-Based Imaging in Cancer Detection and Therapy
Portfolio Management a Tool for Our Time
Project Management in Biopharma: A Necessary Evil or a Source of Competitive Advantage?
Process Map Proposal for The Validation of Genomic Biomarkers
Personalized Healthcare 2010
Principled, Effective Data Mining for Systems Biology
Portfolio Management: a Tool for Our Time
Principled, Effective Data Mining for Systems Biology
Progressive Project Management Focus ®: A Strategy to Accelerate Drug Product Development
Protein Tomography ™ Pictures that prove your theory
Read more about the Molecular Diagnostics Conference in the February 1, 2007 is of Genetic Engineering News.
SCREEN DREAMS: The Promise of Parallel Screening
Senior Management_Disabler or Enabler of Alliance Success
SNPs as powerful tools for Association
Strategic Opportunities In Molecular Diagnostics Sector Review By TSG Partners
Strategic Opportunities in Point-of-Care Diagnostics Sector Review By TSG Partners
Strategic Opportunities In Genomics Tools Sector Review By TSG Partners Strategic Advisors
Successful Pharmacogenomics Business Models
Template Synthesized Nanotubes for Biomedical Delivery Applications.
The Consortium for Metabonomic Toxicology (COMET): Aims, Activities and Achievements
The Challenge of Improving the Drug Discovery Process - An Early ADME Perspective
The Era of ErbB-Receptor-Targeted Therapies: Advances Toward Personalized Medicine
The Future of PCR with the Expiration of PCR Patents
The Need for a New Molecular Diagnostic Business Model to Fit the Needs of Personalized Medicine
The Next Generation of Immunoassay Technologies
TaqMan ® Gene Expression Assays for Validating Hits From Fluorescent Microarrays
Therapeutic Approaches for Prion Disorders
Transcriptional Profiling of Multiple Sclerosis: Towards Improved Diagnosis and Treatment
Trends in Library Design and Synthesis
You've Closed the Deal, Now What? What it Takes to Ensure a Successful Alliance or Partnership
Conferences
CDs
CHI
By Series:
All series
Biomarker & Diagnostics
Bioprocess & Manufacturing
Chemistry
Clinical Trials & Translational Medicine
Drug Discovery & Development
Drug Safety
IT & Informatics
Pharmaceutical Strategy Series
Technology & Tools for Life Sciences
Therapeutics & Targets
Additional Conferences
By Region:
All regions
East Coast
West Coast
Europe
Top Searches
By Series:
All series
Biomarker & Diagnostics
Bioprocess & Manufacturing
Chemistry
Clinical Trials & Translational Medicine
Drug Discovery & Development
Drug Safety
IT & Informatics
Pharmaceutical Strategy Series
Technology & Tools for Life Sciences
Therapeutics & Targets
Additional Conferences
By Region:
All regions
East Coast
West Coast
Europe
Cambridge Healthtech Institute